Top investors in Hong Kong

ORI Capital invests in innovative early-stage biotech companies globally, in the areas of diagnostics, drug delivery, and therapeutics focused on the disease areas with the highest mortality rates: cancer, cardiovascular and neurodegenerative diseases.

The Mills Fabrica is a go-to solutions platform accelerating techstyle and agrifood tech innovations for sustainability and social impact.

We support emerging managers who have access and ability to pick innovators who utilize new technology to re-imagine processes and business models to re-define how we live, work and interact.

Oceanpine Capital is committed to identifying and empowering future disruptors in the global wave of technology innovation, focusing on cutting-edge sectors such as advanced technology, green technology and life sciences, strategically investing in innovative companies with breakthrough and transformative potential.

We acquire and operate publicly traded companies across Asia with Bitcoin treasury strategy and web3 infrastructure focus. The architects behind Asia's Bitcoin treasury companies, operating at the center of digital asset infrastructure build-out across the region.

Creating deep value with deep tech by empowering innovators on their journey to improve the world. Invests in founders leveraging deep technology to transform global industries.

GT Healthcare Capital Partners focuses on "globally leading, revolutionary innovative drugs and medical technologies," combining "technological progress and market application" as investment drivers, with a goal to "transform the medical technology landscape in Asia and globally."

Investing in the deep science and technology that can propel humanity towards a radically better future.